Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

SK bioscience Co.,Ltd. (302440) Stock Price & Analysis

302440 Stock Chart & Stats

$32,750.00$550.00(1.71%)
At close: 3:30 PM GMT+9
$32,500$35,000$37,5003 Aug18 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$31,850.00 - $33,250.00
52-Week Range
$31,500.00 - $61,300.00
Previous Close
$32,200.00
Volume
N/A
Average Volume (3M)
60.82K
Market Cap
KRW 2.57T
Enterprise Value
KRW 2.76T
Total Cash (Recent Filing)
KRW 832.60B
Total Debt (Recent Filing)
KRW 543.37B
Price to Earnings (P/E)
―
Beta
0.32
Next Earnings
Nov 05, 2026 (Est.)
EPS Estimate
-387.97
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Integrated Vaccine Platform

SK bioscience spans vaccine research, clinical development, manufacturing and distribution, giving it control across multiple stages of the product lifecycle. This integrated model can support commercialization, operational learning and participation in both domestic and international vaccine markets over time.

Broad Vaccine Portfolio

Exposure to both routine immunization and pandemic-response products gives SK bioscience a broader commercial base than reliance on one vaccine category alone. This portfolio breadth can support recurring demand from preventive care while preserving participation in large public-health opportunities.

Balance Sheet Resilience

The sizable equity base and moderate debt-to-equity ratio provide a meaningful financial cushion while the company works through weak earnings and cash generation. This capital structure should preserve more flexibility to fund operations and development than a highly leveraged balance sheet would.

Bears Say

Severe Revenue And Profit Deterioration

The steep TTM revenue contraction and continued operating losses represent a major deterioration from the strong profitability recorded in 2021–2022. Persistently negative margins weaken internal funding capacity and raise execution risk until the business can restore sustainable demand and earnings.

Deep Negative Free Cash Flow

Heavy free-cash-flow burn indicates that investment and other cash outflows are not currently supported by operating inflows. If this pattern persists, SK bioscience may face greater pressure to conserve resources or secure funding, limiting flexibility for growth and development.

Rising Leverage With Negative Returns

Although leverage remains moderate, its meaningful increase from previously low levels coincides with negative returns on equity. This suggests capital is not currently producing profits and could gradually reduce financial flexibility if weak earnings and cash generation continue.

SK bioscience Co.,Ltd. News

302440 FAQ

What was SK bioscience Co.,Ltd.’s price range in the past 12 months?
SK bioscience Co.,Ltd. lowest stock price was $31500.00 and its highest was $61300.00 in the past 12 months.
What is SK bioscience Co.,Ltd.’s market cap?
SK bioscience Co.,Ltd.’s market cap is ₩2.57T.
When is SK bioscience Co.,Ltd.’s upcoming earnings report date?
SK bioscience Co.,Ltd.’s next earnings report is estimated for Nov 05, 2026 (not yet confirmed), which is in 3 days.
How were SK bioscience Co.,Ltd.’s earnings last quarter?
SK bioscience Co.,Ltd. released its earnings results on Aug 10, 2026. The company reported -$179.59 earnings per share for the quarter, beating the consensus estimate of -$340.68 by $161.09.
Is SK bioscience Co.,Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does SK bioscience Co.,Ltd. pay dividends?
SK bioscience Co.,Ltd. does not currently pay dividends.
What is SK bioscience Co.,Ltd.’s EPS estimate?
SK bioscience Co.,Ltd.’s EPS estimate is -387.97.
How many shares outstanding does SK bioscience Co.,Ltd. have?
SK bioscience Co.,Ltd. has 78,456,550 shares outstanding.
What happened to SK bioscience Co.,Ltd.’s price movement after its last earnings report?
SK bioscience Co.,Ltd. reported an EPS of -$179.59 in its last earnings report, beating expectations of -$340.68. Following the earnings report the stock price went up 1.085%.
Which hedge fund is a major shareholder of SK bioscience Co.,Ltd.?
Currently, no hedge funds are holding shares in KR:302440
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology